Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Could Plummet On FDA's Warning For Propecia
Seeking Alpha
Tuesday, April 17, 2012 - 10:18am
tags:
Merck, FDA, Propecia, Proscar, GSK, Eli Lilly, Pfizer
Johnson & Johnson Reports Mixed First Quarter Earnings
Yahoo/Business Insider
Tuesday, April 17, 2012 - 8:00am
tags:
JNJ, earnings
Lilly Declares Second-Quarter 2012 Dividend
Yahoo
Monday, April 16, 2012 - 4:04pm
tags:
Eli Lilly, dividends
Questcor Will Skyrocket Into 2013
Seeking Alpha
Monday, April 16, 2012 - 4:03pm
tags:
Questcor, Acthar, Sanofi, Novartis
J&J Must Pay $40 Million to Boston Scientific, Judge Says
Bloomberg
Monday, April 16, 2012 - 4:01pm
tags:
JNJ, Boston Scientific, settlements, patents, coronary stent system
Science Vs. Hedge Funds: Influences On New Drug Approval Process
Seeking Alpha
Monday, April 16, 2012 - 1:49pm
tags:
hedge funds, Arena Pharmaceuticals, Avanir, Chelsea Therapeutics, Dendreon, Neoprobe, Vivus
With Zostavax supplies restored, Merck aims for revival
Fierce Pharma
Monday, April 16, 2012 - 1:46pm
tags:
Merck, Zostavax, shingles
Idenix Will Sink Without Drug Success, Partnership
Motley Fool
Monday, April 16, 2012 - 1:44pm
tags:
Idenix, IDX184, hepatitis C
Supreme Court To Hear Overtime Rep Case Today
Pharmalot
Monday, April 16, 2012 - 1:43pm
tags:
overtime lawsuits, Supreme Court
Amgen’s Sharer: Mostly, ‘I Was An Awful Listener’
Pharmalot
Monday, April 16, 2012 - 1:41pm
tags:
Amgen, Kevin Sharer, Pharma CEOs
FDA Schedules Meeting With Cellceutix on New Psoriasis Drug
Yahoo/Marketwire
Monday, April 16, 2012 - 11:58am
tags:
FDA, Cellceutix, psoriasis, Prurisol
Insider Buy At Novavax Spurs Speculation
Seeking Alpha
Monday, April 16, 2012 - 11:57am
tags:
Novavax
Halozyme Falls After FDA Demands More Data
Bloomberg
Monday, April 16, 2012 - 11:52am
tags:
FDA, Halozyme, HyQ, Baxter International
Achillion: A Compelling 'Buy' Candidate Now
Motley Fool
Monday, April 16, 2012 - 11:51am
tags:
Achillion, ACH-1625, ACH-2684, ACH-2928
How Will Dendreon be Affected by the STOCK Act?
Motley Fool
Monday, April 16, 2012 - 11:30am
tags:
STOCK Act, Dendreon, insider trading, GSK, Pfizer, Novartis, Sanofi
Johnson & Johnson Won't Blow Out Earnings But Still Worth $72.50
Forbes
Monday, April 16, 2012 - 11:28am
tags:
JNJ, earnings
Endocyte Doubles on Ovarian Drug Partnership With Merck
Bloomberg
Monday, April 16, 2012 - 11:28am
tags:
Merck, Endocyte, vintafolide, ovarian cancer
Provectus Pharma treatment viewed positively by doctors
The Fly on the Wall
Monday, April 16, 2012 - 11:27am
tags:
Provectus, physicians, PV-10, metastatic melanoma
Vanda buys Lilly's experimental drug
Reuters
Monday, April 16, 2012 - 11:25am
tags:
Vanda, Eli Lilly, VLY-686, alcoholism
Piramal buys Bayer molecular imaging portfolio
Yahoo/AP
Monday, April 16, 2012 - 11:24am
tags:
Bayer, molecular imaging, Piramal Healthcare

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.